Developmental disability support in Montana

Montana Plans $30M Upgrade for Mental Health and Developmental Disability Facilities

Medical Facts - January 27, 2025

Montana Governor Proposes $30M Upgrade for Mental Health and Developmental Disability FacilitiesMontana is gearing up for a significant transformation in its behavioral health system...

BREAKING NEWS

FDA Review Requested for Hims’ Super Bowl Ad Accuracy

Medical Facts - February 9, 2025

Amid the glitz and glamor of the Super Bowl, a controversial ad from telehealth company Hims & Hers has sparked a firestorm. Released on...

Threat of Brain Drain Undermining U.S. Biomedicine Dominance

February 12, 2025

Lower-Priced Zepbound Vials and Monkey Shipments from Cambodia: Pharmalittle News

January 16, 2025

Scientists Prepare for Potential Changes in Health Funding Under Trump Administration

December 27, 2024

FDA Pauses Study on Amgen’s Obesity Treatment

February 5, 2025

Uncovering the Truth: Amyloid Mafia Debate among STAT Readers

February 22, 2025

FDA Cancels Vaccine Advisory Committee Meeting

February 27, 2025

Challenges of Accessing Effective Rare Disease Treatments

February 5, 2025

jj-acquires-ntra-cellular-therapies-for-146b-expanding-mental-health-drug-portfolio

J&J Acquires Intra-Cellular Therapies for $14.6B, Expanding Mental Health Drug Portfolio

January 13, 2025

Measles Outbreak: Concerns Over Trump Administration’s Messaging

March 2, 2025

Tag: Developmental disability support in Montana

Montana Plans $30M Upgrade for Mental Health and Developmental Disability Facilities

BREAKING NEWS

FDA Review Requested for Hims’ Super Bowl Ad Accuracy

Threat of Brain Drain Undermining U.S. Biomedicine Dominance

Lower-Priced Zepbound Vials and Monkey Shipments from Cambodia: Pharmalittle News

Scientists Prepare for Potential Changes in Health Funding Under Trump Administration

FDA Pauses Study on Amgen’s Obesity Treatment

Uncovering the Truth: Amyloid Mafia Debate among STAT Readers

FDA Cancels Vaccine Advisory Committee Meeting

Challenges of Accessing Effective Rare Disease Treatments

J&J Acquires Intra-Cellular Therapies for $14.6B, Expanding Mental Health Drug Portfolio

Measles Outbreak: Concerns Over Trump Administration’s Messaging

Top News

Axsome submits Alzheimer’s disease drug for FDA approval after Phase 3 trials

Using Humor to Shed Light on the Darkness in Medicine: Dr. Glaucomflecken’s Approach

Optimizing Online Marketing Strategies for GLP-1 Compounded Drugs: Balancing Benefits and Risks

Navigating Aging as LGBTQ+ Individuals: Addressing Past Traumas – KFF Health News

Challenges in School Shooting Prevention Teams – KFF Health News